Clinical trial
Changes in the Gut Microbiota Composition of Healthy Young Volunteers After Administration of Lacticaseibacillus Rhamnosus LRa05: A Placebo-controlled Study
NCT06103240 is registered in ClinicalTrials.gov with Wecare Probiotics Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Changes in the Gut Microbiota Composition of Healthy Young Volunteers After Administration of Lacticaseibacillus Rhamnosus LRa05: A Placebo-controlled Study
- Lead sponsor
- Wecare Probiotics Co., Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 20, 2022
- Completion date
- June 11, 2022
- Enrollment
- 110 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
intestinal flora